But, whether IDO1 activity is able to affect the amount of local tumour-infiltrating lymphocytes, which is an independent prognostic factor in patients with CRC (Waldner et al, 2006; Laghi et al, 2009), remains controversial. This evidence concerns the gene IDO1 and neoplasm.